What Does Intrexon Corporation Do?

Total employees70
HeadquartersGermantown
Founded1998

Precigen, Inc. (NASDAQ: PGEN), formerly known as Intrexon Corporation until its rebranding in 2020, is a clinical-stage biopharmaceutical company pioneering the future of gene and cell therapies. Precigen is dedicated to developing and commercializing transformative therapies for patients with cancer, autoimmune disorders, and infectious diseases. The company leverages its innovative technology platforms, including the UltraCAR-T® platform for CAR-T therapies and the AdenoVerse™ platform for immunotherapies and therapeutic vaccines, to advance a pipeline of novel treatments. The strategic shift from Intrexon's broader synthetic biology focus to Precigen's dedicated biopharmaceutical approach aimed to streamline operations and concentrate on high-value clinical assets.

Where Is Intrexon Corporation's Headquarters?

HQ Function

The headquarters serves as the central hub for corporate strategy, research and development leadership, clinical operations management, and administrative functions.

Notable Features:

The facility likely includes advanced laboratory spaces for gene and cell therapy research, process development, and potentially cGMP-compliant manufacturing capabilities for clinical trial materials. It's designed to foster collaboration and innovation.

Work Culture:

Precigen's work culture is expected to be science-driven, innovative, and patient-focused, with an emphasis on collaboration, agility, and achieving breakthroughs in complex diseases. Employees are likely motivated by the potential to make a significant impact on patients' lives.

HQ Significance:

The Germantown headquarters is significant as it centralizes Precigen's efforts in pioneering next-generation gene and cell therapies, placing it within a prominent U.S. biotechnology corridor with access to talent and research institutions.

Values Reflected in HQ: The headquarters likely reflects Precigen's core values of scientific excellence, innovation, urgency in addressing patient needs, and commitment to quality and precision medicine.

Location:

Precigen's primary operational footprint is in North America (USA) and Europe (Belgium). While its physical offices are concentrated, its clinical trials and collaborations often have a global reach, involving sites and partners in various countries to advance its therapeutic candidates through development and towards potential commercialization worldwide.

Street Address:

20374 Seneca Meadows Parkway, Suite 100

City:

Germantown

State/Province:

Maryland

Country:

USA

Where Else Does Intrexon Corporation Operate Around the World?

Ghent, Belgium

Address: Technologiepark Zwijnaarde 82, 9052 Gent, Belgium (Address for ActoBio Therapeutics, a Precigen company)

Serves as a key European hub for Precigen's research and development in specific therapeutic areas, leveraging local expertise and infrastructure for advancing its innovative AG-based pipeline.

Buying Intent Signals for Intrexon Corporation

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Intrexon Corporation? Meet the Executive Team

As of April 2025, Intrexon Corporation' leadership includes:

Helen Sabzevari - Ph.D., President and Chief Executive Officer
Harry Thomas Jr. - Chief Financial Officer
Mary L. Marbach - Ph.D., Chief Legal Officer and Corporate Secretary
Dimitrios Goundis - Ph.D., Senior Vice President, Head of Business Development
David A. fancelli - Ph.D., Senior Vice President, Head of CMC
Concetta C. Donst - Senior Vice President, Head of Regulatory Affairs and Quality Assurance

Who's Investing in Intrexon Corporation?

Intrexon Corporation has been backed by several prominent investors over the years, including:

Randal J. Kirk (Historically, through Third Security, a major investor in Intrexon)
Major institutional investors such as Vanguard Group, BlackRock, State Street Corporation (as a publicly traded company, PGEN)

What Leadership Changes Has Intrexon Corporation Seen Recently?

Hire0
Exits0

Precigen's executive leadership team has shown stability. Recent public announcements focus more on clinical and financial updates rather than major executive turnover. Any significant changes are typically filed with the SEC.

What Technology (Tech Stack) Is Used byIntrexon Corporation?

Discover the tools Intrexon Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Intrexon Corporation Email Formats and Examples

Precigen likely uses standard corporate email formats. The most common patterns for companies of its size and type involve combinations of first name, last name, and initials.

[first_initial][last]@precigen.com

Format

hhsabzevari@precigen.com

Example

80%

Success rate

What's the Latest News About Intrexon Corporation?

Precigen Press ReleaseMarch 5, 2024

Precigen Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

Precigen provided financial results for Q4 and full year 2023, along with updates on its clinical pipeline, including advancements in its UltraCAR-T and AdenoVerse platforms....more

Precigen Press ReleaseFebruary 20, 2024

Precigen Announces Publication of Landmark Phase 1/2 Data for PRGN-2012 in The Lancet eBioMedicine

Precigen announced the publication of positive Phase 1/2 data for its PRGN-2012 AdenoVerse immunotherapy in recurrent respiratory papillomatosis (RRP) in The Lancet eBioMedicine, highlighting its potential as a transformative treatment....more

Precigen Press ReleaseJanuary 8, 2024

Precigen to Provide Corporate Update and Present at the 42nd Annual J.P. Morgan Healthcare Conference

Precigen announced its participation in the J.P. Morgan Healthcare Conference, where CEO Helen Sabzevari provided a corporate update and outlined strategic priorities for 2024....more

Precigen Press ReleaseNovember 7, 2023

Precigen Reports Third Quarter 2023 Financial Results and Business Updates

Precigen shared its Q3 2023 financial performance and progress across its therapeutic programs, emphasizing upcoming clinical milestones....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Intrexon Corporation, are just a search away.